New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

However, guidelines already recommend that antithrombotics after TAVR consist of lifelong SAPT (aspirin 75-100 mg daily or ...

Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI Scientific Sessions 2025, will kick off on ...

Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced ...

Eisenhower Health in Rancho Mirage recently celebrated 10 years of performing Transcatheter Aortic Valve Replacement, or TAVR. It’s the first and only hospital in the Coachella Valley to offer this ...

has not been previously reported in patients with severe AS undergoing transcatheter aortic valve replacement (TAVR). Hypothesis: Higher LVEDWS to LVESWS ratio assessed by echocardiography prior to ...

As technology trends toward less invasive methods and sheath sizes become smaller, the use of a total percutaneous approach to endovascular repair of aortic pathology is becoming more common.

--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement ... are delivered through a percutaneous, 29F outer diameter ...

This technique entails percutaneous delivery of a bioprosthetic valve ... The search parameters were as follows: TI (Title) = (“Transcatheter Aortic Valve Replacement” OR “transcatheter aortic valve ...